SIFI S.p.A.

Industry

  • Pharmaceuticals
    • Nutraceuticals
    • Vaccines
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
  • In Vitro Diagnostics
  • Biotechnology
See more in Biomedtracker

Latest on SIFI S.p.A.

Pink Sheet

Chikungunya Vaccine, Hemophilia B Gene Therapy Among 14 Products On Track For EU Approval

 
• By Vibha Sharma

The European Medicines Agency has recommended granting pan-EU marketing approval to 14 new products, including Valneva ’s chikungunya vaccine Ixchiq and Pfizer / Spark Therapeutics ’ hemophilia B ge

Pink Sheet

EU Crunch Time For Myriad Drugs Marks A Busy May Meeting For CHMP

 
• By Neena Brizmohun

The European Medicines Agency is this week due to decide whether to recommend in favor of pan-EU marketing authorization for fidanacogene elaparvovec, Pfizer / Spark Therapeutics ’ gene therapy for h

Scrip

Deal Watch: AbbVie Leads J.P. Morgan Deal Rush, But BI, Genentech And Lilly Also Big Players

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie Taps Anima’s mRNA Platform, Immu

Pink Sheet

Accelerated Assessment Requests Fall Flat At EMA

 
• By Neena Brizmohun

Only four requests for a fast-track drug review were submitted by companies to the European Medicines Agency in the first half of 2022 and none of them were granted. This compares with 17 requests for